pulmonary arterial hypertension
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
313 |
4. Check minimum number of eventsNone |
313 |
5. Include endpointsNone |
313 |
6. Filter based on genotype QC (FinnGen only) |
313 |
Control definitions (FinnGen only)
- Control exclude
- I9_HYPERTENSION
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- I27
- Name in latin
- Hypertensio pulmonalis primaria
Similar endpoints
↥List of similar endpoints to
Hypertension, Pulmonary Arterial
based on the number of shared cases.
Similar with more cases:
- Secondary right heart disease
- Other pulmonary heart/vessel disease
- Pulmonary heart disease, diseases of pulmonary circulation
- Hypertensive diseases (excluding secondary)
- Hypertensive diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2950 | 1579 | 1316 |
| Only index persons | 1759 | 1100 | 659 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.05 | 0.04 |
| Only index persons | 0.03 | 0.04 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 65.26 | 67.03 | 63.32 |
| Only index persons | 68.00 | 69.52 | 65.46 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 313 | 206 | 107 |
| Unadjusted period prevalence (%) | 0.06 | 0.07 | 0.05 |
| Median age at first event (years) | 61.27 | 60.22 | 63.28 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 291
- Matched controls
- 2911
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I27.0
ICD-10 Finland
Primary pulmonary hypertension
+∞
323.0
270
*
205
Kela drug reimbursment
Chronic hypertension
+∞
187.4
159
*
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
242.8
146.1
140
11
G04BE03
ATC
sildenafil; oral
183.1
113.8
113
10
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
+∞
103.4
93
*
C03CA01
ATC
furosemide; systemic
16.4
98.0
219
455
B01AA03
ATC
warfarin; systemic
16.2
92.5
181
268
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
569.2
88.1
83
*
C03DA01
ATC
spironolactone; oral
21.7
84.1
132
107
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
14.7
80.3
156
211
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
11.2
67.8
154
265
C02KX04
ATC
macitentan; oral
716.7
61.1
58
*
R06.0
ICD-10 Finland
Dyspnoea
9.3
60.9
159
334
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
655.8
56.6
54
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
9.2
55.4
138
259
GD1AA
NOMESCO Finland
Thorax X-ray examination
7.7
55.3
214
773
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
14.8
55.0
98
96
I50.9
ICD-10 Finland
Heart failure, unspecified
10.7
53.1
115
167
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
19.6
45.8
71
47
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
19.6
42.1
65
42
C02KX01
ATC
bosentan; oral
+∞
41.7
39
*
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
57.1
41.2
48
10
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
7.9
37.5
96
171
I50.0
ICD-10 Finland
Congestive heart failure
11.8
35.3
68
73
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
16.2
35.1
58
44
C01AA05
ATC
digoxin; systemic
8.8
34.9
81
122
WX740
NOMESCO Finland
Nitrogen oxide therapy
72.4
33.9
38
6
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
12.5
33.7
63
63
I48
ICD-10 Finland
Atrial fibrillation and flutter
5.3
32.0
119
334
XF622
NOMESCO Finland
Measurement of minute volume of heart
+∞
30.8
29
*
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
46.8
30.7
37
9
AP2
HP
Catheterization of the right side of the heart
172.6
30.3
31
*
I10
ICD-10 Finland
Essential (primary) hypertension
4.5
30.0
144
520
J96.1
ICD-10 Finland
Chronic respiratory failure
24.3
29.7
42
20
WX872
NOMESCO Finland
Intensive care
19.5
29.5
45
27
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
9.0
29.4
66
92
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
15.0
26.7
45
35
C07AB07
ATC
bisoprolol; oral
3.9
26.3
168
758
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
10.1
26.3
54
64
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.2
24.4
114
384
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
+∞
24.3
23
*
R4110
NOMESCO Finland
Physiotherapy
4.0
24.2
122
440
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
5.1
23.6
83
209
TPH04
NOMESCO Finland
Cathetrisation of vein
4.6
23.3
93
267
B01AC11
ATC
iloprost; inhalant, parenteral
+∞
23.2
22
*
A12BA01
ATC
potassium chloride; oral
21.7
22.7
33
17
H02AB06
ATC
prednisolone; systemic
3.5
22.5
171
847
C02KX02
ATC
ambrisentan; oral
+∞
22.2
21
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
12.7
21.7
39
35
M04AA01
ATC
allopurinol; systemic
6.0
21.7
64
130
G04BE08
ATC
tadalafil; oral
118.5
20.9
22
*
Z3226
NOMESCO Finland
Physiotherapist
4.2
20.8
92
288
C08CA01
ATC
amlodipine; oral
4.0
20.7
100
339
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
7.8
19.8
47
70
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
6.6
18.9
51
91
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
14.9
18.7
31
23
ZXE40
NOMESCO Finland
More than seven and less than nine hours
19.2
18.6
28
16
103
Kela drug reimbursment
Diabetes, insulin-treated
3.9
18.3
86
280
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.9
18.1
64
158
TPH07
NOMESCO Finland
Cathetrisation of artery
5.7
18.0
55
115
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.3
18.0
115
478
383
Kela drug reimbursment
Selexipag
+∞
17.9
17
*
XF620
NOMESCO Finland
Examination of circulation with color method
101.3
17.8
19
*
AN1
HP
Coronary angiography
5.6
17.8
55
117
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.3
17.7
72
205
XF400
NOMESCO Finland
ECG with 12 standard connections
4.0
17.2
78
245
A46
ICD-10 Finland
Erysipelas
4.6
17.2
65
172
K93
ICPC
Pulmonary embolism
37.5
16.9
21
6
I27.1
ICD-10 Finland
Kyphoscoliotic heart disease
+∞
16.8
16
*
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
+∞
16.8
16
*
GD1AD
NOMESCO Finland
Thorax CT examination
8.6
16.4
36
47
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
6.8
16.4
42
70
C08CA05
ATC
nifedipine; systemic
8.9
16.3
35
44
C08DB01
ATC
diltiazem; oral
10.1
16.2
32
35
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.8
16.0
75
241
Z2446
NOMESCO Finland
Social worker
6.4
15.9
43
77
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
8.1
15.8
36
50
B01AC27
ATC
selexipag; oral
+∞
15.8
15
*
Z94.2
ICD-10 Finland
Lung transplant status
168.6
15.6
16
*
B01AB05
ATC
enoxaparin; parenteral
3.0
15.6
113
501
XF404
NOMESCO Finland
Ambulatory ECG
5.1
15.5
51
116
207
Kela drug reimbursment
Chronic arrhythmias
4.1
15.4
66
195
R03AC02
ATC
salbutamol; inhalant
2.8
15.4
170
981
B01AB10
ATC
tinzaparin; parenteral
6.3
15.4
42
76
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.5
15.2
47
99
ZXE20
NOMESCO Finland
More than three and less than five hours
4.1
15.2
64
186
C08CA02
ATC
felodipine; oral
9.1
15.2
32
39
L04AA06
ATC
mycophenolic acid; systemic
33.7
15.0
19
6
GD2SN
NOMESCO Finland
Lung ventilation SPECT
59.9
14.9
17
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
3.6
14.9
78
270
201
Kela drug reimbursment
Chronic cardiac insufficiency
6.4
14.9
40
71
AP3
HP
Catheterization of the right and left side of the heart
84.4
14.7
16
*
334
Kela drug reimbursment
Treprostinil
+∞
14.7
14
*
B01AC21
ATC
treprostinil; parenteral
+∞
14.7
14
*
42600
ICD-8 Finland
Pulmonary heart disease, Cor pulmonale
+∞
14.7
14
*
127
Kela drug reimbursment
Transplant complication
38.2
14.6
18
5
62
HP
Catheterization and pressure measurement of the right side of the heart
157.5
14.6
15
*
GDG10
NOMESCO Finland
Bilateral transplantation of lung
157.5
14.6
15
*
C09AA02
ATC
enalapril; systemic
4.1
14.1
58
165
R28
ICPC
Limited function/disability (R)
25.3
14.0
19
8
ZX108
NOMESCO Finland
Inhalation
25.3
14.0
19
8
Z01.8
ICD-10 Finland
Other specified special examinations
3.2
13.9
84
326
ZX120
NOMESCO Finland
Intravenous
4.3
13.7
54
147
GD1UN
NOMESCO Finland
Lung circulation SPECT
78.9
13.7
15
*
J01MA12
ATC
levofloxacin; systemic
3.5
13.7
73
257
FB1BC
NOMESCO Finland
Extensive angiography of arteria pulmonalis
+∞
13.6
13
*
FBB20
NOMESCO Finland
Thrombendarterectomy of pulmonary artery in chronic obstruction
+∞
13.6
13
*
C02KX05
ATC
riociguat; oral
146.5
13.6
14
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.6
13.5
35
59
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
5.9
13.4
38
72
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.7
13.4
34
56
TFP20
NOMESCO Finland
Cardiodefibrillation
6.0
13.2
37
69
C07AB02
ATC
metoprolol; systemic
3.4
13.1
70
246
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
7.4
13.1
31
46
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
52.4
13.0
15
*
Z3231
NOMESCO Finland
Registered nurse
2.8
12.9
102
466
TGC00
NOMESCO Finland
Bronchial lavation
13.1
12.8
22
18
Z2221
NOMESCO Finland
Medical doctor
2.7
12.6
107
510
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
25.7
12.6
17
7
SPAT1262
SPAT
Handing over of treatment supplies
3.5
12.6
64
217
R50.9
ICD-10 Finland
Fever, unspecified
3.7
12.5
58
182
A10BA02
ATC
metformin; oral
3.1
12.2
77
303
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.7
12.2
42
100
K78
ICPC
Atrial fibrillation/flutter
5.4
12.1
37
77
XG466
NOMESCO Finland
Sleep oxymetry
9.0
12.1
25
30
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.2
11.8
46
124
I50.1
ICD-10 Finland
Left ventricular failure
6.9
11.7
29
46
J45.9
ICD-10 Finland
Asthma, unspecified
3.3
11.7
64
229
M10.9
ICD-10 Finland
Gout, unspecified
7.1
11.6
28
43
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
6.2
11.6
31
55
GD1FN
NOMESCO Finland
Lung ventilation isotope imaging
124.7
11.5
12
*
G47.3
ICD-10 Finland
Sleep apnoea
3.4
11.4
58
196
R5140
NOMESCO Finland
Monitoring the use of the aid
5.0
11.3
37
83
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
7.6
11.3
26
37
C03AA03
ATC
hydrochlorothiazide; oral
6.2
11.2
30
53
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.8
11.2
38
89
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.2
11.2
63
230
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
12.6
11.0
19
16
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
16.3
11.0
17
11
T90
ICPC
Diabetes non-insulin dependent
3.2
10.8
61
222
WX892
NOMESCO Finland
Monitored bed care
5.0
10.8
35
78
3AC01
NOMESCO Finland
NA
22.5
10.8
15
7
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
7.8
10.7
24
33
ZXD05
NOMESCO Finland
Urgent procedure
2.5
10.6
100
499
C01DA14
ATC
isosorbide mononitrate; oral
3.4
10.6
53
177
FXA20
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure
113.9
10.5
11
*
PH7FT
NOMESCO Finland
Inmplantation of filter to inferior vena cava with radiological guidance
113.9
10.5
11
*
4160A
ICD-9 Finland
Chronic pulmonary heart disease, Primary pulmonary hypertension
+∞
10.5
10
*
M34.0
ICD-10 Finland
Progressive systemic sclerosis
+∞
10.5
10
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
5.8
10.4
29
54
XG410
NOMESCO Finland
Flow-volume spirometry
6.5
10.2
26
43
C01BD01
ATC
amiodarone; systemic
9.7
10.2
20
22
C02AC05
ATC
moxonidine; oral
41.6
10.0
12
*
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
7.0
10.0
24
37
A10BB12
ATC
glimepiride; oral
6.0
9.9
27
49
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
6.2
9.9
26
45
A10BH01
ATC
sitagliptin; oral
5.2
9.8
30
63
I50
ICD-10 Finland
Heart failure
9.6
9.7
19
21
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.4
9.6
35
88
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
18.3
9.5
14
8
A07AA09
ATC
vancomycin; oral
31.1
9.5
12
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
4.5
9.4
33
80
R04.0
ICD-10 Finland
Epistaxis
4.4
9.4
34
85
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
22.6
9.4
13
6
4019X
ICD-9 Finland
Essential hypertension, Unspecified
+∞
9.4
9
*
I20.99
ICD-10 Finland
Angina pectoris, unspecified
5.5
9.4
27
53
C09BA02
ATC
enalapril and diuretics; systemic
8.2
9.3
20
26
L04AX01
ATC
azathioprine; systemic
6.0
9.3
25
45
A10BB01
ATC
glibenclamide; oral
6.7
9.0
22
35
C07AA07
ATC
sotalol; systemic
6.7
9.0
22
35
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
11.2
8.9
16
15
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
9.9
8.9
17
18
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
3.2
8.7
46
159
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
51.5
8.7
10
*
C09CA01
ATC
losartan; oral
2.8
8.7
59
239
N18.8
ICD-10 Finland
Other chronic renal failure
16.9
8.6
13
8
M34.1
ICD-10 Finland
CR(E)ST syndrome
28.4
8.5
11
*
S97
ICPC
Chronic ulcer skin
5.6
8.5
24
46
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.6
8.5
67
299
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
8.3
8.5
18
23
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
92.6
8.5
9
*
FB1AC
NOMESCO Finland
Angiography of arteria pulmonalis
92.6
8.5
9
*
K99
ICPC
Cardiovascular disease other
9.9
8.4
16
17
K82
ICPC
Pulmonary heart disease
+∞
8.4
8
*
PH3BC
NOMESCO Finland
Extensive flebography of internal organs with X-ray
+∞
8.4
8
*
N02AX02
ATC
tramadol; systemic, rectal
2.1
8.3
127
779
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
5.3
8.2
24
48
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
5.3
8.2
24
48
C09DA06
ATC
candesartan and diuretics; oral
7.2
8.2
19
28
WX882
NOMESCO Finland
High dependency care
6.6
8.2
20
32
J94.8
ICD-10 Finland
Other specified pleural conditions
17.8
8.1
12
7
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
34.4
8.1
10
*
RK110
NOMESCO Finland
NA
34.4
8.1
10
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.3
8.1
40
132
WX725
NOMESCO Finland
Noninvasive ventilation
6.0
8.0
21
37
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.3
7.8
28
70
A10AE04
ATC
insulin glargine; parenteral
4.8
7.8
25
56
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
8.4
7.7
16
20
R02
ICPC
Shortness of breath/dyspnoea
3.0
7.7
44
161
GBB00
NOMESCO Finland
Tracheostomy
19.0
7.7
11
6
I26
ICD-10 Finland
Pulmonary embolism
19.0
7.7
11
6
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
4.1
7.6
29
77
XF402
NOMESCO Finland
ECG with work load test
3.5
7.5
34
105
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
4.7
7.5
24
54
7AX01
NOMESCO Finland
NA
82.0
7.4
8
*
XX4BW
NOMESCO Finland
NA
82.0
7.4
8
*
TFC20
NOMESCO Finland
Catheterisation of both sides of heart
82.0
7.4
8
*
C08CA13
ATC
lercanidipine; oral
4.2
7.4
27
69
FL1AC
NOMESCO Finland
Left cardioangiography
11.3
7.4
13
12
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
+∞
7.3
7
*
P01BA02
ATC
hydroxychloroquine; oral
3.3
7.3
36
119
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.4
7.3
34
108
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
7.2
125
792
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.2
7.2
37
126
A10AE05
ATC
insulin detemir; parenteral
6.3
7.2
18
30
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
8.3
7.2
15
19
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.8
7.2
48
193
C09AA05
ATC
ramipril; oral
2.4
7.2
66
318
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
7.2
112
681
C02EA02
ATC
NA
12.4
7.1
12
10
J01MA14
ATC
moxifloxacin; systemic
3.4
7.1
33
104
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
2.8
7.1
47
186
R03BB04
ATC
tiotropium bromide; inhalant
3.3
7.0
35
117
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
5.1
7.0
21
44
SPAT1254
SPAT
Administration of medicine
2.7
6.9
50
211
R4190
NOMESCO Finland
Nutritional therapy
5.6
6.9
19
36
A10BH05
ATC
linagliptin; oral
6.4
6.9
17
28
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
4.9
6.9
21
45
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
11.3
6.9
12
11
TFC10
NOMESCO Finland
Catheterisation of left atrium or ventricle
11.3
6.9
12
11
RK320
NOMESCO Finland
NA
17.2
6.8
10
6
Q25.0
ICD-10 Finland
Patent ductus arteriosus
41.0
6.8
8
*
I83.2
ICD-10 Finland
Varicose veins of lower extremities with both ulcer and inflammation
41.0
6.8
8
*
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
41.0
6.8
8
*
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
6.7
74
388
Q21.10
ICD-10 Finland
Persistent ostium secundum
23.1
6.7
9
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.0
6.7
38
138
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.6
6.7
22
51
E66.00
ICD-10 Finland
Metabolic syndrome
8.1
6.7
14
18
XFE00
NOMESCO Finland
Epicardial ultrasonography
8.1
6.7
14
18
M10.0
ICD-10 Finland
Idiopathic gout
7.1
6.6
15
22
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
10.4
6.6
12
12
WX720
NOMESCO Finland
Own respiration
6.4
6.6
16
26
J01FF01
ATC
clindamycin; systemic
2.1
6.5
78
424
D64.9
ICD-10 Finland
Anaemia, unspecified
3.0
6.5
37
135
A02BC02
ATC
pantoprazole; systemic
1.9
6.5
174
1280
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
71.3
6.4
7
*
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
5.4
6.4
18
35
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
5.8
6.4
17
31
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.8
6.4
41
162
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
18.5
6.3
9
5
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
+∞
6.3
6
*
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
+∞
6.3
6
*
I28.9
ICD-10 Finland
Disease of pulmonary vessels, unspecified
+∞
6.3
6
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.3
6.2
60
294
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
6.2
107
673
N05CF01
ATC
zopiclone; oral
2.0
6.1
99
603
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
8.9
6.1
12
14
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
6.9
6.1
14
21
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
10.3
6.1
11
11
H11.3
ICD-10 Finland
Conjunctival haemorrhage
4.5
6.1
20
47
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
144
271
8.99
81.93
4.5
1.8
%
18.3
22.9
3.38
129
234
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
213
609
8.82
81.08
12.5
2.8
ng/l
1485.2
1224.4
0.73
208
507
(3036489) Thrombin time
83
78
14.12
80.23
5.7
2.3
s
21.3
22.0
0.28
78
69
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
53
25
25.32
72.43
1.5
1.2
u/ml
1.6
1.5
—
18
8
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
52
25
24.74
70.47
1.5
1.3
u/ml
2.2
4.0
—
24
10
(4306422)
50
26
22.70
65.46
1.3
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
170
469
6.75
64.00
8.7
2.2
umol/l
387.0
9568.6
3.09
164
399
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
58
47
14.92
60.67
8.9
2.8
u/ml
0.3
0.3
0.02
45
29
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
46
29
18.42
54.88
1.3
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
105
209
7.06
54.41
16.5
6.2
mmol/l
1.2
0.9
0.29
80
169
(3019060) Gas panel - Arterial blood
77
129
7.59
46.54
5.5
4.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
210
875
5.25
44.71
35.2
6.0
inr
1.7
1.2
7.11
68
242
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
163
561
4.98
44.20
5.5
2.2
mg/l
3.4
3.1
0.69
156
470
(3027315) Oxygen [Partial pressure] in Blood
42
34
14.11
43.55
8.2
4.2
kpa
6.3
8.6
4.48
42
34
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
60
90
8.01
39.75
23.4
6.7
mmol/l
24.0
24.5
0.46
54
83
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
130
427
4.50
36.21
7.5
3.1
ng/l
897.3
421.0
0.28
117
326
(3037522) Nuclear Ab [Titer] in Serum
102
281
4.90
35.52
1.6
1.4
titre
640.0
551.7
0.23
30
58
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
96
254
5.01
35.09
2.8
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
95
253
4.96
34.39
2.9
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
116
369
4.41
33.34
2.8
1.8
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
103
300
4.63
33.22
11.3
3.2
mmol/l
0.8
0.8
2.41
97
273
(4268621)
29
20
15.88
32.63
2.7
2.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
129
456
4.11
31.87
8.9
1.6
mg/l
1.6
1.4
0.23
100
348
(3023368) Bacteria identified in Blood by Culture
144
559
3.92
30.92
7.1
3.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
60
120
5.95
29.82
21.8
7.2
mmol/l
24.5
24.8
0.17
60
120
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
29
24
13.22
29.40
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
29
24
13.22
29.40
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
29
24
13.22
29.40
1.3
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
74
184
4.96
28.73
6.7
3.0
mmol/l
1.7
2.0
0.18
58
134
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
29
25
12.68
28.66
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
29
25
12.68
28.66
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
29
25
12.68
28.66
1.3
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
180
844
3.67
28.42
7.4
3.1
ng/l
126.9
34.9
0.42
156
556
(42870588) Differential panel, method unspecified - Blood
169
771
3.59
27.66
13.5
5.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
193
990
3.48
25.55
10.0
3.6
g/l
34.8
35.3
0.73
187
913
(3019230) Fractional oxyhemoglobin in Venous blood
29
30
10.55
25.38
8.9
5.9
%
61.3
63.3
0.14
29
30
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
34
44
8.55
25.16
4.1
1.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
200
1059
3.46
24.92
13.7
5.5
%
0.7
0.7
0.19
192
970
(3033658) Prothrombin time (PT) actual/Normal
134
557
3.46
24.89
12.3
3.2
%
72.1
90.1
7.51
134
543
(3013290) Carbon dioxide [Partial pressure] in Blood
30
34
9.65
24.58
9.0
4.2
kpa
5.1
4.9
0.49
30
34
(3012501) Base excess in Blood by calculation
30
34
9.65
24.58
9.0
4.2
mmol/l
2.3
1.9
0.29
23
19
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
32
40
8.80
24.33
3.8
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
27
27
10.85
24.16
3.8
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
27
10.85
24.16
4.1
1.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
90
294
3.89
24.07
42.7
17.9
inr
1.8
1.2
—
9
41
(3006504) Eosinophils/100 leukocytes in Blood
202
1091
3.40
24.05
13.8
5.4
%
2.4
2.9
2.84
194
998
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
20
12
17.74
23.93
5.3
1.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
202
1098
3.37
23.65
14.1
5.7
%
9.1
8.6
1.24
194
1011
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
40
67
6.70
23.57
4.1
3.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
65
170
4.56
23.44
26.0
4.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
28
7
43.77
23.08
1.4
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
30
37
8.86
23.02
1.1
1.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
203
1119
3.32
22.97
14.1
5.6
%
25.0
29.0
5.63
195
1025
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
33
46
7.90
22.92
4.3
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
60
151
4.68
22.66
2.1
2.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
28
33
9.22
22.23
4.3
1.8
—
—
—
0
0
(44790048)
23
21
11.74
21.79
4.6
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
21
11.74
21.79
4.1
1.8
—
—
—
0
0
(44790049)
23
21
11.74
21.79
4.6
1.6
—
—
—
0
0
(44806118)
23
21
11.74
21.79
4.6
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
23
21
11.74
21.79
5.0
1.6
—
—
—
0
0
(44790047)
23
21
11.74
21.79
4.6
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
204
1156
3.20
21.46
13.6
5.3
e9/l
0.6
0.6
2.07
191
1004
(3001122) Ferritin [Mass/volume] in Serum or Plasma
184
985
3.11
21.38
6.1
2.4
ug/l
111.9
120.9
0.20
179
894
(3006315) Basophils [#/volume] in Blood
204
1165
3.16
20.99
13.6
5.3
e9/l
0.0
0.0
0.52
191
1010
(3013115) Eosinophils [#/volume] in Blood
208
1206
3.16
20.74
14.4
5.5
e9/l
0.2
0.2
0.93
196
1059
(3018010) Neutrophils/100 leukocytes in Blood
196
1109
3.05
20.23
13.8
5.4
%
59.6
56.1
3.55
188
1022
(3019198) Lymphocytes [#/volume] in Blood
205
1190
3.09
20.18
14.2
5.4
e9/l
1.6
2.0
3.06
193
1052
(3026782) Osmolality of Urine
107
434
3.23
20.00
4.4
2.4
mosm/kgh2o
505.7
562.2
2.06
95
373
(3027945) Reticulocytes/100 erythrocytes in Blood
73
233
3.78
19.89
3.1
2.9
%
2.1
1.6
2.51
68
209
(3042936) Bacteria identified in Isolate by Culture
82
287
3.52
19.41
3.8
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
42
90
5.23
19.08
31.5
6.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
27
37
7.89
18.95
1.1
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
16
10
16.81
18.63
4.5
3.2
ug/l
34.0
141.8
—
16
10
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
43
98
4.93
18.17
7.1
3.9
mmol/l
24.5
24.5
0.01
36
90
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54
148
4.20
18.11
2.1
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
39
83
5.23
17.82
2.3
2.1
g/l
1.1
1.5
1.23
32
70
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
89
5.01
17.36
2.6
1.8
g/l
3.9
3.5
1.17
31
60
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
89
5.01
17.36
2.6
1.8
g/l
6.8
7.2
0.53
31
63
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
89
5.01
17.36
2.6
1.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
20
21
10.11
17.17
1.2
1.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
194
1157
2.78
17.03
17.6
5.3
mmol/l
1.2
1.2
7.74
172
994
(3000850) Epithelial cells [#/volume] in Urine
105
457
2.95
16.97
4.2
2.2
e6/l
3.6
5.1
1.42
92
405
(3013650) Neutrophils [#/volume] in Blood by Automated count
212
1340
2.80
16.31
17.4
8.6
e9/l
4.3
3.9
1.67
200
1176
(3017143) Hepatitis C virus Ab [Presence] in Serum
66
226
3.43
15.94
1.5
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
135
689
2.69
15.91
6.7
3.2
ph
7.4
7.4
0.78
30
124
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
181
1068
2.65
15.82
17.0
4.8
mmol/l
1.2
1.2
8.72
171
953
(3042733) HLA Ab [Presence] in Serum
15
0
+∞
15.76
6.2
0.0
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
14
10
14.61
15.13
2.0
1.3
%
96.3
97.6
—
14
10
(3023520) Reticulocytes [#/volume] in Blood
54
168
3.68
15.05
2.5
2.9
e9/l
86.4
63.6
2.40
42
132
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
83
4.77
14.94
2.7
1.9
g/l
3.2
3.0
0.46
31
61
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
127
650
2.61
14.63
4.5
2.0
u/l
165.2
289.6
0.52
122
615
(3034426) Prothrombin time (PT)
19
7
28.76
14.45
1.3
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
20
28
7.56
13.71
5.6
2.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
145
811
2.47
13.61
5.5
2.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
118
601
2.55
13.54
12.5
6.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
19
26
7.72
13.26
3.9
3.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
46
140
3.68
13.19
1.2
1.2
iu/ml
357.0
149.6
—
9
55
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
29
62
5.05
13.11
2.3
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
16
5
33.59
12.69
4.0
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
29
64
4.89
12.64
1.4
1.5
—
73.3
—
0
6
(3013826) Glucose [Moles/volume] in Serum or Plasma
202
1341
2.43
12.54
15.0
3.7
mmol/l
6.7
6.4
1.62
195
1245
(3027456) Digoxin [Moles/volume] in Serum or Plasma
25
49
5.46
12.43
3.8
2.5
nmol/l
0.8
0.9
0.23
20
39
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
17
22
8.11
12.40
2.8
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
52
180
3.27
12.19
8.3
3.3
%
0.6
0.8
0.27
18
46
(3002582) Erythrocytes [#/volume] in Urine
127
697
2.38
12.12
5.9
2.7
e6/l
55.4
177.9
0.62
114
528
(3009343) pH of Capillary blood
43
136
3.51
11.60
8.0
4.2
ph
7.4
7.4
—
7
10
(3002179) Metamyelocytes/100 leukocytes in Blood
48
163
3.30
11.59
8.2
3.3
%
0.5
0.4
0.07
13
31
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
42
131
3.55
11.57
7.8
4.2
mmol/l
2.0
1.8
0.14
32
101
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
17
24
7.43
11.53
2.9
1.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
118
639
2.36
11.49
5.8
2.7
e6/l
0.6
0.5
0.16
105
476
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
16
8
20.98
11.25
1.8
3.7
%
156.5
108.9
—
16
8
(36304419) Bacteria [Presence] in Urine
115
622
2.34
11.18
5.7
2.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
17
25
7.13
11.13
2.8
1.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
47
162
3.24
11.06
8.7
3.3
%
0.0
0.3
0.57
15
35
(3014007) Fractional oxyhemoglobin in Arterial blood
39
121
3.54
10.82
35.7
7.0
%
91.7
93.8
0.53
39
121
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
17
26
6.86
10.74
3.3
3.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
15
20
7.83
10.65
2.6
3.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
48
172
3.12
10.58
8.8
3.3
%
0.1
0.1
0.07
17
42
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
38
118
3.53
10.52
36.4
6.8
%
0.7
0.7
0.10
38
118
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
38
119
3.50
10.39
36.5
6.9
%
1.3
1.4
0.56
38
119
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
15
8
19.61
10.36
1.7
3.8
%
195.3
132.9
—
15
8
(3021589) Normoblasts [#/volume] in Blood
164
1052
2.17
10.29
22.4
8.3
e9/l
0.0
0.0
0.22
146
854
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
25
58
4.60
10.25
1.4
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
21
7.45
10.22
2.9
2.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
18
32
5.91
9.86
3.2
2.5
%
14.4
15.3
—
7
16
(46235355) HIV 1 and 2 tests - Meaningful Use set
79
381
2.44
9.78
1.7
1.8
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
39
129
3.31
9.78
4.3
3.1
pmol/l
4.1
4.6
2.55
33
115
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
14
19
7.67
9.78
1.4
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
35
108
3.52
9.77
8.1
4.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
60
255
2.67
9.66
3.4
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
68
309
2.53
9.55
1.6
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
37
5.40
9.48
2.9
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
93
490
2.28
9.37
3.4
2.7
mg/l
477.7
189.9
0.28
72
281
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
22
50
4.66
9.24
2.8
1.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
19
38
5.26
9.21
4.1
3.9
e9/l
4.5
3.9
0.61
19
38
(3021901) Oxygen saturation in Capillary blood
18
35
5.40
8.99
4.3
3.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
14
21
6.93
8.97
2.3
2.1
%
87.1
88.8
0.29
14
21
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
39
5.12
8.96
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
39
5.12
8.96
1.2
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
58
253
2.59
8.82
4.3
2.5
umol/l
9.8
7.7
0.65
53
219
(4010399)
44
167
2.90
8.73
2.5
1.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
18
36
5.24
8.72
3.2
2.3
umol/l
54.1
35.2
0.55
18
31
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
40
4.99
8.71
4.4
3.9
%
59.8
57.7
0.38
19
40
(3018095) Leukocytes [#/volume] in Urine
133
834
2.03
8.39
7.2
3.2
e6/l
71.2
158.3
0.49
114
569
(3020682) Albumin/Creatinine [Ratio] in Urine
93
511
2.17
8.33
3.9
3.2
mg/mmol
10.8
5.4
0.49
75
284
(3020891) Body temperature
28
83
3.61
8.29
7.4
5.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
22
55
4.23
8.21
1.2
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
12
7
17.76
8.14
2.3
11.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
232
1786
2.16
8.13
12.1
3.8
mm/h
13.5
11.5
1.31
224
1591
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
75
382
2.27
8.07
1.3
1.2
iu/ml
27.6
31.3
0.20
19
116
(40757373) Influenza virus identified in Isolate
11
5
22.72
8.07
2.3
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
18
39
4.84
7.98
7.6
5.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
12
8
15.53
7.77
1.0
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
22
59
3.94
7.49
1.8
1.2
u/ml
33.0
2.4
—
5
8
(3009508) Creatinine [Moles/volume] in Urine
94
541
2.05
7.34
3.5
2.6
mmol/l
6.2
7.1
1.55
87
442
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
30
5.20
7.26
1.3
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
88
497
2.07
7.22
9.0
4.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
22
61
3.80
7.16
1.8
1.2
u/ml
16.7
10.9
—
6
11
(3051651) Icteric interference index of Serum or Plasma
10
13
7.91
7.16
2.2
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
72
379
2.17
7.08
4.8
2.5
e6/l
3.3
2.8
0.19
49
204
(3026008) Bacteria identified in Urine by Culture
122
778
1.93
7.06
3.5
2.9
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
16
35
4.76
7.01
1.1
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
19
48
4.15
7.00
1.3
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
13
24
5.61
6.83
2.2
2.4
ug/min
52.5
83.8
—
6
14
(3009871) Measles virus Ab [Titer] in Serum
10
6
17.16
6.79
1.2
2.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
14
7.35
6.73
3.0
1.7
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
17
41
4.33
6.63
1.2
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
9
12.61
6.63
4.4
1.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
112
711
1.90
6.47
4.0
2.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
17
42
4.22
6.44
1.3
1.4
—
—
—
0
0
(3000492) Spirometry study
45
202
2.43
6.39
3.0
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
22
5.63
6.34
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
26
5.17
6.28
1.2
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
34
134
2.72
6.28
1.6
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
34
135
2.70
6.19
1.8
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
16
39
4.27
6.16
1.8
5.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
10
8
12.86
6.12
1.0
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
23
5.39
6.05
1.0
1.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
54
271
2.20
5.92
4.4
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
84
498
1.94
5.88
2.3
1.3
g/l
2.0
2.1
0.32
63
270
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
34
139
2.62
5.85
1.6
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
21
65
3.39
5.84
3.4
2.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
28
4.80
5.79
1.2
1.0
—
—
—
0
0
(4062490)
10
18
5.71
5.35
1.1
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
19
59
3.36
5.26
3.7
4.1
mg/l
66.3
27.3
0.38
13
48
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
25
92
2.87
5.24
6.4
3.1
%
1.4
1.2
0.46
25
92
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
5
0
+∞
5.22
6.6
0.0
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
19
60
3.31
5.13
3.7
4.0
mg/l
32.2
139.7
0.52
14
49
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
69
400
1.93
5.11
4.1
2.4
e6/l
1.3
1.0
0.27
45
219
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
88
553
1.82
5.07
3.6
2.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
11
23
4.92
5.05
2.4
2.2
—
—
—
0
0
(3044889) 12 lead EKG panel
203
1614
1.73
5.03
11.5
3.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
204
1630
1.72
4.90
7.5
3.9
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
11
8.38
4.59
1.9
1.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
16
49
3.39
4.53
1.1
2.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
74
459
1.80
4.39
1.8
1.7
pmol/l
424.6
16086241.4
0.50
63
373
(3018405) Lactate [Moles/volume] in Arterial blood
20
72
2.90
4.37
5.8
6.1
mmol/l
1.8
1.1
1.05
20
72
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
41
209
2.11
4.31
4.0
3.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
9
9.08
4.30
3.5
1.8
—
—
—
0
0
(3004451) EKG impression Narrative
7
6
11.89
4.29
1.3
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
14
41
3.53
4.23
1.3
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
11
27
4.19
4.19
2.1
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
185
1482
1.61
4.03
5.3
2.8
u/l
63.2
42.0
3.69
178
1352
(3044242) Glucose [Moles/volume] in Arterial blood
7
7
10.19
4.03
1.1
11.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
70
2.83
4.00
1.4
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
132
978
1.60
3.98
3.5
2.2
nmol/l
73.8
79.1
1.55
124
851
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
11
7.43
3.88
1.1
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
5
12.20
3.78
1.3
1.2
—
—
—
0
0
(3013512) EKG study
98
686
1.62
3.68
6.5
3.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
9
7.92
3.57
3.9
1.8
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
9
18
5.11
3.39
1.0
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
10
7.13
3.38
3.9
1.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
14
5.83
3.36
2.3
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
14
5.83
3.36
1.1
1.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
86
598
1.60
3.27
1.8
1.5
nmol/l
19.1
21.1
0.55
81
486
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
205
2337
0.64
3.25
4.7
4.1
mmol/l
6.1
5.7
3.17
190
2076
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
138
1072
1.51
3.19
5.9
3.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
8
16
5.10
3.07
1.7
1.9
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
6
8
7.62
3.07
1.0
1.4
%
102.3
108.1
—
6
8
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
12
5.94
3.03
1.9
3.1
u/ml
886.0
816.7
—
7
12
(3013293) Extractable nuclear Ab [Presence] in Serum
5
5
10.13
2.99
2.2
2.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
13
46
2.91
2.95
3.4
2.0
g/l
121.0
129.5
—
8
29
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
9
6.77
2.88
1.2
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
212
2378
0.66
2.79
4.8
4.4
mmol/l
2.4
2.8
11.59
201
2138
(3037121) Protein [Mass/volume] in Urine
17
72
2.44
2.77
2.0
2.3
g/l
0.3
0.2
—
7
26
(3019309) Folate [Moles/volume] in Red Blood Cells
68
465
1.59
2.74
1.9
1.7
nmol/l
1036.5
1251.1
1.28
59
330
(3008037) Lactate [Moles/volume] in Venous blood
11
37
3.04
2.72
4.8
2.1
mmol/l
1.6
1.6
0.11
11
37
(3011648) Oxygen content in Venous blood
6
10
6.09
2.71
1.0
15.0
%
12.0
12.4
—
6
10
(3042631) Mycobacterium sp identified in Specimen
10
32
3.20
2.67
7.0
4.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
32
3.20
2.67
2.0
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
41
247
1.76
2.66
1.5
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
53
777
0.62
2.63
2.1
2.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
204
2296
0.68
2.61
4.4
4.0
mmol/l
1.4
1.6
7.65
192
2062
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
20
4.08
2.58
2.1
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
5
7
7.24
2.56
1.4
2.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
11
5.54
2.55
1.3
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
11
5.54
2.55
1.3
1.5
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
6
11
5.54
2.55
5.2
3.8
nmol/l
327.3
61.7
—
6
11
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
11
5.54
2.55
8.7
5.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
46
290
1.69
2.55
1.2
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
142
1152
1.43
2.46
6.4
3.5
estimate
0.0
0.0
0.00
48
201
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
78
2.25
2.35
1.3
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
75
543
1.50
2.33
5.3
3.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
27
149
1.89
2.33
5.1
3.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
13
53
2.52
2.31
2.1
1.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
79
2.22
2.29
1.3
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
13
4.68
2.28
1.5
2.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
140
1145
1.40
2.26
8.4
4.8
estimate
0.0
0.0
0.50
48
200
(3011412) CD3 cells [#/volume] in Blood
7
18
3.95
2.26
1.9
1.7
e9/l
1.4
0.9
—
7
7
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
208
2313
0.70
2.25
4.5
4.0
mmol/l
4.2
4.8
14.26
198
2097
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
29
3.16
2.24
1.0
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
31
182
1.78
2.21
8.8
3.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
24
3.39
2.19
1.0
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
17
81
2.16
2.17
1.3
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
30
3.06
2.16
2.3
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
30
3.06
2.16
1.2
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
23
124
1.92
2.13
1.3
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
10
5.06
2.08
1.6
2.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
20
3.56
2.06
1.0
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
16
76
2.16
2.06
1.4
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
18
91
2.04
1.99
2.7
1.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
138
1145
1.37
1.98
6.3
3.4
estimate
0.0
0.0
0.00
44
203
(3041354) Potassium [Moles/volume] in Venous blood
7
21
3.38
1.97
4.0
1.5
mmol/l
4.1
4.0
—
7
21
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
21
3.38
1.97
5.3
2.9
nmol/l
34.6
3.2
—
7
21
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
11
4.60
1.95
1.4
1.4
mmol/l
2.2
1.8
—
5
11
(3017446) Testosterone [Moles/volume] in Serum or Plasma
5
143
0.34
1.92
1.6
2.0
nmol/l
8.2
13.7
—
5
125
(3029937) Albumin [Presence] in Urine by Test strip
81
618
1.42
1.90
6.7
3.6
estimate
0.0
0.0
0.50
48
201
(3015377) Calcium [Moles/volume] in Serum or Plasma
108
866
1.38
1.90
5.7
3.1
mmol/l
2.3
2.4
2.91
103
714
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
53
0.00
1.89
0.0
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
20
108
1.91
1.86
2.8
2.3
e6/l
0.2
0.3
0.17
20
102
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
17
3.58
1.84
1.5
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
17
3.58
1.84
1.5
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
23
3.09
1.81
1.0
1.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
9
36
2.54
1.75
5.7
2.1
mmol/l
10.2
6.9
—
9
36
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
9
187
0.47
1.68
1.1
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
190
0.46
1.67
1.3
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
201
2211
0.75
1.67
4.1
3.5
mmol/l
1.3
1.2
0.98
191
1965
(3045424) Erythrocytes [Presence] in Urine
8
31
2.62
1.67
3.3
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
19
3.20
1.67
1.0
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
14
3.61
1.62
1.6
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
32
2.54
1.61
2.1
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
20
3.04
1.59
1.5
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
20
3.04
1.59
1.5
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
20
3.04
1.59
1.5
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
50
2.24
1.59
1.3
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
26
162
1.66
1.55
5.7
2.0
ml/min/173m2
51.1
70.4
1.74
12
55
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
42
0.00
1.53
0.0
1.5
—
—
—
0
0
(3035880) pH of Pleural fluid
5
15
3.37
1.53
1.2
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
77
604
1.36
1.52
5.7
3.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
27
2.63
1.52
1.3
2.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
21
124
1.74
1.51
2.2
2.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
21
2.89
1.51
4.5
1.5
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
6
21
2.89
1.51
4.5
1.5
mmol/l
104.2
107.8
—
6
21
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
11
214
0.50
1.50
1.6
2.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
17
96
1.82
1.42
1.6
1.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
117
986
1.30
1.41
2.2
1.9
pmol/l
81.1
97.9
4.07
70
492
(3000330) Specific gravity of Urine by Test strip
19
113
1.73
1.35
2.9
3.4
—
—
—
0
0
(4281824)
6
25
2.43
1.25
1.7
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
21
320
0.63
1.23
3.1
4.3
%
33.7
32.7
0.15
15
182
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
19
2.66
1.22
1.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
19
2.66
1.22
1.6
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
12
64
1.91
1.19
1.2
2.2
u/l
1.0
5723.7
—
5
18
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
50
2.03
1.17
1.1
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
14
233
0.58
1.17
1.8
2.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
48
365
1.37
1.16
1.3
1.2
u/ml
43.1
12.3
0.61
12
131
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
5
21
2.40
1.09
1.2
1.1
u/l
40.0
87.8
—
5
15
(3002385) Erythrocyte distribution width [Ratio]
217
2010
1.26
1.09
53.7
14.3
%
14.9
13.6
16.75
212
1963
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
52
1.95
1.07
1.1
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
22
2.29
1.04
1.2
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
22
2.29
1.04
1.2
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
29
206
1.45
1.03
1.2
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
15
91
1.68
1.02
1.5
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
102
878
1.24
0.99
6.4
3.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
52
1.75
0.93
2.3
2.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
25
177
1.45
0.91
3.9
3.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
8
42
1.93
0.89
5.9
3.2
mg/l
31.4
35.2
—
8
24
(1761482) Bacteria [#/volume] in Urine by Culture
10
56
1.81
0.89
3.0
4.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
202
0.63
0.86
1.3
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
32
1.89
0.82
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
32
1.89
0.82
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
98
0.50
0.79
2.0
1.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
116
1.49
0.76
1.4
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
196
1831
1.19
0.75
5.6
3.8
pmol/l
15.7
14.8
4.71
183
1630
(3003694) ABO and Rh group [Type] in Blood
72
619
1.21
0.70
1.4
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
38
470
0.78
0.70
3.2
4.3
%
19.1
19.9
0.16
15
225
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
205
2165
0.85
0.69
6.6
4.6
mmol/mol
42.1
38.4
5.92
198
1959
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
33
260
1.30
0.67
2.1
4.2
ug/l
38.3
43.0
0.05
22
214
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
29
1.74
0.64
4.0
3.5
u/ml
19.4
54.3
—
5
29
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
30
1.68
0.61
1.2
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
65
561
1.20
0.61
1.4
1.3
u/ml
0.6
1.4
1.94
17
125
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
52
1.55
0.60
1.4
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
111
0.62
0.59
1.7
1.6
—
—
—
0
0
(4146454)
0
23
0.00
0.58
0.0
2.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
35
1.73
0.58
1.3
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
37
446
0.81
0.56
1.5
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
123
0.64
0.56
1.9
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
30
369
0.79
0.55
1.3
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
45
1.57
0.49
2.1
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
47
1.50
0.48
1.1
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
58
511
1.17
0.45
5.5
3.9
kg/l
1.0
1.0
—
9
74
(3000764) Benzodiazepines [Presence] in Urine
10
69
1.46
0.45
2.4
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
10
69
1.46
0.45
2.4
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
69
1.46
0.45
2.4
1.4
—
—
—
0
0
(4035726)
24
194
1.26
0.43
1.8
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
31
1.62
0.43
1.2
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
31
1.62
0.43
1.2
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
31
1.62
0.43
1.2
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
91
0.65
0.43
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
32
1.57
0.42
1.2
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
32
1.57
0.42
1.2
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
70
1.44
0.42
2.4
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
35
1.44
0.39
1.0
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
250
2564
0.88
0.38
38.1
10.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
76
0.65
0.36
1.0
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
77
0.64
0.36
1.4
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
249
2425
1.13
0.36
44.8
11.8
mg/l
22.0
24.7
0.68
238
1833
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
20
242
0.81
0.34
2.0
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
30
348
0.85
0.33
2.3
2.8
ug/l
0.6
0.8
0.79
17
225
(40768804) Tissue Pathology biopsy report
89
954
0.91
0.31
2.9
2.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
13
162
0.79
0.29
2.7
2.5
—
20.1
—
0
7
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
71
0.70
0.26
1.8
1.6
—
—
—
0
0
(4034850)
9
76
1.19
0.25
10.7
9.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
77
1.17
0.24
1.1
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
226
2212
1.08
0.21
7.9
4.5
mu/l
2.1
1.9
1.56
215
1963
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
12
0.00
0.21
0.0
1.2
—
7.5
—
0
12
(3019832) Treponema pallidum Ab [Presence] in Serum
23
202
1.15
0.21
1.2
1.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(4024509)
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
9.9
—
751.1
—
0
14
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
13.2
—
1350.9
—
0
14
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
53
494
1.09
0.19
4.5
2.7
mmol/l
2.5
2.5
0.21
46
421
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
54
577
0.92
0.18
3.7
5.0
ug/l
2.1
3.6
0.89
43
505
(3049717) Cytology report of Urine Cyto stain
8
68
1.18
0.16
2.1
2.9
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
13
149
0.87
0.14
1.4
1.4
—
25.7
—
0
12
(3011288) Drugs identified in Urine by Screen method
5
47
1.06
0.09
5.8
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
54
1.11
0.09
1.5
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
55
1.09
0.09
1.2
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
58
602
0.96
0.09
1.5
1.5
mmol/l
1.4
1.3
0.59
52
512
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
56
1.07
0.08
3.0
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
12
107
1.13
0.08
1.2
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
6
57
1.05
0.08
2.2
1.4
pmol/l
168.2
150.7
—
6
57
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
63
0.79
0.08
1.2
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
154
0.90
0.08
1.5
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
150
1475
1.03
0.08
3.3
3.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
64
1.10
0.08
3.0
1.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
6
70
0.85
0.07
1.5
1.1
—
1.1
—
0
10
(3019225) pH of Specimen
24
255
0.94
0.07
6.0
3.8
—
—
—
0
0
(1002224) Polysomnography panel
7
80
0.87
0.07
1.0
1.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
226
2244
1.03
0.05
37.9
10.8
ml/min/173m2
71.7
80.1
5.12
202
1798
(3002256) Pathology report gross observation
30
288
1.05
0.04
1.2
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
138
0.94
0.02
1.1
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
222
2212
1.01
0.01
50.4
12.7
%
37.4
39.5
2.07
160
1589
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
32
319
1.00
0.00
10.3
5.9
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
0
8
0.00
0.00
0.0
1.0
—
7.5
—
0
8
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
14.2
—
0
5
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
4.8
—
0
5
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
16.1
—
0
5
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
9.5
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
0
6
0.00
0.00
0.0
5.3
—
3.6
—
0
6
(3004959) Base excess in Arterial cord blood by calculation
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
10.2
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
7.8
—
0
5
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_HYPTENSPUL and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_HYPTENSPUL | 4.18 [3.33, 5.24] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.19 |
During the follow-up period (1.1.1998 — 31.12.2019), 588 out of 1066 females with I9_HYPTENSPUL died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_HYPTENSPUL | 4.585 [3.19, 6.59] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.026 |
During the follow-up period (1.1.1998 — 31.12.2019), 390 out of 643 males with I9_HYPTENSPUL died.
Mortality risk
Mortality risk for people of age
years, who have I9_HYPTENSPUL.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.421% | 0.888% |
| 5 | 2.404% | 5.63% |
| 10 | 6.259% | 13.925% |
| 15 | 11.562% | 25.475% |
| 20 | 19.153% | 39.831% |
Relationships between endpoints
↥Index endpoint: I9_HYPTENSPUL – Hypertension, Pulmonary Arterial
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data